Yahoo
NasdaqCM - Delayed Quote USD

BioNexus Gene Lab Corp. (BGLC)

1.4500 -0.0400 (-2.68%)
At close: September 4 at 4:00:00 PM EDT
1.4200 -0.0300 (-2.07%)
After hours: September 4 at 7:30:03 PM EDT
Chart Range Bar
Loading chart for BGLC
  • Previous Close 1.4900
  • Open 1.3900
  • Bid 0.9792 x 200
  • Ask 1.8800 x 200
  • Day's Range 1.3900 - 1.4500
  • 52 Week Range 1.0700 - 6.1000
  • Volume 740
  • Avg. Volume 96,008
  • Market Cap (intraday) 4.253M
  • Beta (5Y Monthly) 2.20
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

www.bionexusgenelab.com

19

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BGLC
63.29%
S&P 500 (^GSPC)
12.75%

1-Year Return

BGLC
74.52%
S&P 500 (^GSPC)
18.71%

3-Year Return

BGLC
90.76%
S&P 500 (^GSPC)
70.93%

5-Year Return

BGLC
99.14%
S&P 500 (^GSPC)
70.18%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -82.36%

  • Return on Assets (ttm)

    -18.99%

  • Return on Equity (ttm)

    -33.66%

  • Revenue (ttm)

    3.13M

  • Net Income Avi to Common (ttm)

    -2.58M

  • Diluted EPS (ttm)

    -1.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.52M

  • Total Debt/Equity (mrq)

    4.16%

  • Levered Free Cash Flow (ttm)

    68.31k

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: